| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | AIMMUNE THERAPEUTICS INC COM | 3,835,830 | 78,443,000 | 39.37% | ||
| 2 | AERIE PHARMACEUTICALS INC | 1,574,749 | 59,604,000 | 29.91% | ||
| 3 | ALDER BIOPHARMACEUTICALS INC | 995,396 | 20,704,000 | 10.39% | ||
| 4 | EPIZYME INC COM | 1,526,637 | 18,472,000 | 9.27% | ||
| 5 | NANOSTRING TECHNOLOGIES INC | 679,033 | 15,142,000 | 7.60% | ||
| 6 | NEXVET BIOPHARMA PUB LTD CO | 894,695 | 3,338,000 | 1.68% | ||
| 7 | ZAFGEN INC COM | 663,780 | 2,111,000 | 1.06% | ||
| 8 | OREXIGEN THERAPEUTICS INC | 542,755 | 944,000 | 0.47% | ||
| 9 | ACCELERON PHARMA | 19,910 | 508,000 | 0.25% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001144204-17-007450, filed 2017.02.10).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
